Literature DB >> 15923142

Trypanosoma equiperdum: master of disguise or historical mistake?

Filip Claes1, Philippe Büscher, Louis Touratier, Bruno Maria Goddeeris.   

Abstract

After 100 years of research, only a small number of laboratory strains of Trypanosoma equiperdum exists, and the history of most of the strains is unknown. No definitive diagnosis of dourine can be made at the serological or molecular level. Only clinical signs are pathognomonic and international screening relies on an outdated cross-reactive serological test (the complement-fixation test) from 1915, resulting in serious consequences at the practical level. Despite many characterization attempts, no clear picture has emerged of the position of T. equiperdum within the Trypanozoon group. In this article, we highlight the controversies that exist regarding T. equiperdum, and the overlap that occurs with Trypanosoma evansi and Trypanosoma brucei brucei. By revisiting the published data, from the early decades of discovery to the recent serological- and molecular-characterization studies, a new hypothesis arises in which T. equiperdum no longer exists as a separate species and in which current strains can be divided into T. evansi (the historical mistake) and Trypanosoma brucei equiperdum (the master of disguise). Hence, dourine is a disease caused by specific host immune responses to a T. b. equiperdum or T. evansi infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923142     DOI: 10.1016/j.pt.2005.05.010

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  38 in total

1.  Developmental regulation and extracellular release of a VSG expression-site-associated gene product from Trypanosoma brucei bloodstream forms.

Authors:  Eleanor M Barnwell; Frederick J van Deursen; Laura Jeacock; Katherine A Smith; Rick M Maizels; Alvaro Acosta-Serrano; Keith Matthews
Journal:  J Cell Sci       Date:  2010-09-07       Impact factor: 5.285

Review 2.  Transmission dynamics: critical questions and challenges.

Authors:  Janis Antonovics
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-05       Impact factor: 6.237

3.  Biology of Trypanosoma (Trypanozoon) evansi in experimental heterologous mammalian hosts.

Authors:  K K Misra; S Roy; A Choudhury
Journal:  J Parasit Dis       Date:  2015-01-20

4.  The gene product of a Trypanosoma equiperdum ortholog of the cAMP-dependent protein kinase regulatory subunit is a monomeric protein that is not capable of binding cyclic nucleotides.

Authors:  José Bubis; Juan Carlos Martínez; Maritza Calabokis; Joilyneth Ferreira; Carlos E Sanz-Rodríguez; Victoria Navas; José Leonardo Escalona; Yurong Guo; Susan S Taylor
Journal:  Biochimie       Date:  2017-12-27       Impact factor: 4.079

5.  Single point mutations in ATP synthase compensate for mitochondrial genome loss in trypanosomes.

Authors:  Samuel Dean; Matthew K Gould; Caroline E Dewar; Achim C Schnaufer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

6.  Futile import of tRNAs and proteins into the mitochondrion of Trypanosoma brucei evansi.

Authors:  Zdeněk Paris; Hassan Hashimi; Sijia Lun; Juan D Alfonzo; Julius Lukeš
Journal:  Mol Biochem Parasitol       Date:  2010-12-30       Impact factor: 1.759

7.  Evolution of dyskinetoplastic trypanosomes: how, and how often?

Authors:  Achim Schnaufer
Journal:  Trends Parasitol       Date:  2010-12

8.  Adaptations of Trypanosoma brucei to gradual loss of kinetoplast DNA: Trypanosoma equiperdum and Trypanosoma evansi are petite mutants of T. brucei.

Authors:  De-Hua Lai; Hassan Hashimi; Zhao-Rong Lun; Francisco J Ayala; Julius Lukes
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

9.  Population genetics of Trypanosoma evansi from camel in the Sudan.

Authors:  Bashir Salim; Thierry de Meeûs; Mohammed A Bakheit; Joseph Kamau; Ichiro Nakamura; Chihiro Sugimoto
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07

10.  Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness.

Authors:  Filip Claes; Suman K Vodnala; Nick van Reet; Nathalie Boucher; Hilda Lunden-Miguel; Theo Baltz; Bruno Maria Goddeeris; Philippe Büscher; Martin E Rottenberg
Journal:  PLoS Negl Trop Dis       Date:  2009-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.